Family · Pharmaceutical analytical standards
Lacosamide
An antiepileptic of the functionalised amino acid class, discovered at the University of Houston in the 1990s and approved in 2008 in Europe and the United States for focal seizures. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It acts on neuronal sodium channels in an unusual way: it enhances their 'slow' inactivation while leaving the fast one untouched. Its activity comes from just one of its two enantiomers, the R form.
No product matches your search.
EDQM standards 5
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
